Beam Therapeutics Inc. Net Debt

Net Debt of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt growth rates and interactive chart. Net debt is the sum of all interest-bearing debt (short-term and long-term) minus cash and short-term investments. A positive number indicates the company's total debt exceeds its cash and short-term investments balances, while a negative number means the company has more cash than its total debt. This figure is also used in Enterprise value calculation.

Highlights and Quick Summary

  • Net Debt for the quarter ending September 30, 2022 was $-917 Million (a -7.24% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt increased by 12.1%
  • Annual Net Debt for 2021 was $-818 Million (a 324.37% increase from previous year)
  • Annual Net Debt for 2020 was $-193 Million (a 221.93% increase from previous year)
  • Annual Net Debt for 2019 was $-59.8 Million (a -59.13% decrease from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt of Beam Therapeutics Inc.

Most recent Net Debtof BEAM including historical data for past 10 years.

Interactive Chart of Net Debt of Beam Therapeutics Inc.

Beam Therapeutics Inc. Net Debt for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $-916.55 $-988.12 $-1,072.6 –
2021 $-817.65 $-787.41 $-472.28 $-366.48 $-817.65
2020 $-192.67 $-168.22 $-191.76 $-217.69 $-192.67
2019 – – – $-60.61 $-59.85
2018 – – – $-146.44 $-146.44
2017 – – – – $-1.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com